Milenic D - Search Results

1

Are radiation oncologists serious about systemic radiation therapy and if not, should we be?

Wallner PE, Coleman CN, Brechbiel M, Milenic D, Tripuraneni P. Wallner PE, et al. Among authors: milenic d. Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):1-2. doi: 10.1016/j.ijrobp.2004.06.256. Int J Radiat Oncol Biol Phys. 2004. PMID: 15337532 No abstract available.

2

Sensitization of tumor to ²¹²Pb radioimmunotherapy by gemcitabine involves initial abrogation of G2 arrest and blocked DNA damage repair by interference with Rad51.

Yong KJ, Milenic DE, Baidoo KE, Brechbiel MW. Yong KJ, et al. Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1119-26. doi: 10.1016/j.ijrobp.2012.09.015. Epub 2012 Nov 29. Int J Radiat Oncol Biol Phys. 2013. PMID: 23200172 Free PMC article.

3

Targeting of radio-isotopes for cancer therapy.

Milenic DE, Brechbiel MW. Milenic DE, et al. Cancer Biol Ther. 2004 Apr;3(4):361-70. doi: 10.4161/cbt.3.4.790. Epub 2004 Apr 3. Cancer Biol Ther. 2004. PMID: 14976424 Free article. Review.

4

Antibody-targeted radiation cancer therapy.

Milenic DE, Brady ED, Brechbiel MW. Milenic DE, et al. Nat Rev Drug Discov. 2004 Jun;3(6):488-99. doi: 10.1038/nrd1413. Nat Rev Drug Discov. 2004. PMID: 15173838 Review. No abstract available.

5

Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease.

Milenic DE, Baidoo KE, Kim YS, Brechbiel MW. Milenic DE, et al. MAbs. 2015;7(1):255-64. doi: 10.4161/19420862.2014.985160. MAbs. 2015. PMID: 25587678 Free PMC article.

6

Impact of α-targeted radiation therapy on gene expression in a pre-clinical model for disseminated peritoneal disease when combined with paclitaxel.

Yong KJ, Milenic DE, Baidoo KE, Brechbiel MW. Yong KJ, et al. PLoS One. 2014 Sep 30;9(9):e108511. doi: 10.1371/journal.pone.0108511. eCollection 2014. PLoS One. 2014. PMID: 25268703 Free PMC article.

7

Antibody guided precision radiation therapy.

Brady ED, Milenic DE, Brechbiel MW. Brady ED, et al. Among authors: milenic de. Discov Med. 2004 Jun;4(22):213-9. Discov Med. 2004. PMID: 20704989 Free article.

8

Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts.

Yong KJ, Milenic DE, Baidoo KE, Brechbiel MW. Yong KJ, et al. Among authors: milenic de. Int J Mol Sci. 2016 May 16;17(5):736. doi: 10.3390/ijms17050736. Int J Mol Sci. 2016. PMID: 27196891 Free PMC article.

9

Potentiation of high-LET radiation by gemcitabine: targeting HER2 with trastuzumab to treat disseminated peritoneal disease.

Milenic DE, Garmestani K, Brady ED, Albert PS, Abdulla A, Flynn J, Brechbiel MW. Milenic DE, et al. Clin Cancer Res. 2007 Mar 15;13(6):1926-35. doi: 10.1158/1078-0432.CCR-06-2300. Clin Cancer Res. 2007. PMID: 17363549

10

(212)Pb-radioimmunotherapy induces G(2) cell-cycle arrest and delays DNA damage repair in tumor xenografts in a model for disseminated intraperitoneal disease.

Yong KJ, Milenic DE, Baidoo KE, Brechbiel MW. Yong KJ, et al. Mol Cancer Ther. 2012 Mar;11(3):639-48. doi: 10.1158/1535-7163.MCT-11-0671. Epub 2012 Jan 11. Mol Cancer Ther. 2012. PMID: 22238365 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters